@Open-Systems-Pharmacology

Open Systems Pharmacology

Latest suite release can be found here:

Pinned repositories

  1. Forum

    Discussion forum for the Open Systems Pharmacology Project

    16 5

  2. Vision-Mission

    Vision & Mission of Open Systems Pharmacology

    2 1

  3. Suite

    Open Systems Pharmacology Suite Setup

    Ruby 48 14

  4. PK-Sim

    PK-Sim® is a comprehensive software tool for whole-body physiologically based pharmacokinetic modeling

    C# 19 14

  5. MoBi

    MoBi® is a software tool for multiscale physiological modeling and simulation

    C# 6 3

  6. ACoP-2018-Workshop

    PK-Sim® & MoBi® (OSPS®) workshop on integrating PBPK with QSP

    2

  • WIP: Protein Abundance Database

    Updated Oct 19, 2018
  • PK-Sim® is a comprehensive software tool for whole-body physiologically based pharmacokinetic modeling

    C# 19 14 Updated Oct 17, 2018
  • Core functionalities of the Open Systems Pharmacology Suite

    C# 1 4 Updated Oct 16, 2018
  • MoBi® is a software tool for multiscale physiological modeling and simulation

    C# 6 3 Updated Oct 16, 2018
  • Open Systems Pharmacology - Live Documentation

    JavaScript 3 Updated Oct 11, 2018
  • R 6 Updated Oct 10, 2018
  • (Matlab) Reporting-Engine

    Matlab 4 Updated Sep 27, 2018
  • Calculation engine for models built with PK-Sim® or MoBi®

    C++ 3 Updated Sep 14, 2018
  • Open Systems Pharmacology Suite Setup

    Ruby 48 14 Updated Sep 13, 2018
  • Collection of Matlab® functions for the processing of PK-Sim® or MoBi® models

    Matlab 1 2 Updated Sep 13, 2018
  • Installation Validation Tool for the Open Systems Pharmacology Suite

    C# 1 3 Updated Sep 13, 2018
  • Whole-body PBPK model of rifampicin as CYP3A4 and P-gp DDI perpetrator drug

    1 Updated Aug 18, 2018
  • Concentration data from studies performed during proprietary drug development programs by Bayer

    Updated Aug 17, 2018
  • Documentation files (chm and pdf) for the Open Systems Pharmacology Suite

    1 Updated Aug 16, 2018
  • Whole-body PBPK model of alfentanil as CYP3A4 DDI victim drug

    1 Updated Aug 14, 2018
  • Whole-body PBPK model of itraconazole as CYP3A4 and P-gp DDI perpetrator drug

    Updated Aug 9, 2018
  • Whole-body PBPK model of clarithromycin as CYP3A4 and P-gp DDI perpetrator drug

    Updated Aug 9, 2018
  • Whole-body PBPK model of midazolam as CYP3A4 DDI victim drug

    Updated Aug 9, 2018
  • Whole-body PBPK model of digoxin as P-gp DDI victim drug

    1 2 Updated Aug 9, 2018
  • Modeling of published clinical Rifampicin-Midazolam-DDI studies for model evaluation

    Updated Aug 9, 2018
  • Modeling of published clinical Rifampicin-Alfentanil-DDI studies for model evaluation

    Updated Aug 9, 2018
  • Modeling of published clinical Rifampicin-Digoxin-DDI studies for model evaluation

    Updated Aug 9, 2018
  • Modeling of published clinical Itraconazole-Midazolam-DDI studies for model evaluation

    Updated Aug 9, 2018
  • Modeling of published clinical Itraconazole-Digoxin-DDI studies for model evaluation

    Updated Aug 9, 2018
  • Modeling of published clinical Clarithromycin-Midazolam-DDI studies for model evaluation

    Updated Aug 9, 2018
  • Modeling of published clinical Clarithromycin-Digoxin-DDI studies for model evaluation

    Updated Aug 9, 2018
  • Open Systems Pharmacology Website (www.open-systems-pharmacology.org)

    CSS 2 Updated Aug 7, 2018
  • PK-Sim® & MoBi® (OSPS®) workshop on integrating PBPK with QSP

    2 Updated Aug 7, 2018
  • PK-Sim® & MoBi® workshop on integrating PBPK with QSP

    1 Updated Jul 30, 2018
  • PK-Sim® & MoBi® (OSPS®) workshop on integrating PBPK with QSP

    Updated Jul 30, 2018